Literature DB >> 26989

Pus, deoxyribonucleic acid, and sputum viscosity.

R Picot, I Das, L Reid.   

Abstract

On 100 sputum specimens selected from patients suffering from chronic bronchitis, bronchiectasis, asthma, and cystic fibrosis total deoxyribonucleic acid (DNA) content has been related to macroscopic type, to total dry weight yield, and to the apparent viscosity of the secretion at 1350 s-1: since DNA may be present, either as fibres or within cells, in one-third of the specimens the contribution of each form to the apparent viscosity was assessed. The effect on sputum viscosity of the addition of DNA in vitro has also been studied. Whereas between mucoid, mucopurulent, and purulent macroscopic types a significant difference in total DNA and dry weight yield has been found, viscosity was not significantly correlated with purulence. Similarly, the concentration of either cells or fibres correlated significantly with total DNA but not with viscosity. The in vitro addition of DNA to sputum caused a significant increase in its viscosity, and reasons for the differences between the iv vivo and in vitro effect are discussed. Certain constituents of purulent sputum tend to increase viscosity and others to reduce it, and the influence of these varies in the several diseases studied.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26989      PMCID: PMC470876          DOI: 10.1136/thx.33.2.235

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

1.  A STUDY OF TECHNIQUES FOR THE EXAMINATION OF SPUTUM IN A FIELD SURVEY OF CHRONIC BRONCHITIS.

Authors:  D L MILLER
Journal:  Am Rev Respir Dis       Date:  1963-10

2.  RELEASE AND BREAKDOWN OF SIALIC ACID FROM HUMAN SALIVARY MUCIN AND ITS ROLE IN THE FORMATION OF DENTAL PLAQUE.

Authors:  S A LEACH
Journal:  Nature       Date:  1963-08-03       Impact factor: 49.962

3.  SUBSTRATE SPECIFICITY OF PROTEASE ACTIVITIES IN PURULENT SPUTUM.

Authors:  J LIEBERMAN; B M TRIMMER; N B KURNICK
Journal:  Lab Invest       Date:  1965-03       Impact factor: 5.662

4.  Proteolytic enzyme activity and the role of desoxyribose nucleic acid (DNA) in cystic fibrosis sputum.

Authors:  J LIEBERMAN; N B KURNICK
Journal:  Pediatrics       Date:  1963-06       Impact factor: 7.124

5.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

6.  Mucus rheology: relation to structure and function.

Authors:  M Litt; M A Khan; D P Wolf
Journal:  Biorheology       Date:  1976-02       Impact factor: 1.875

7.  Influence of mist tent therapy on sputum viscosity and water content in cystic fibrosis.

Authors:  M Rosenbluth; V Chernick
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

8.  The viscoelasticity of fractionated canine tracheal mucus.

Authors:  M Litt; M A Khan; L W Chakrin; J R Wardell; P Christian
Journal:  Biorheology       Date:  1974-03       Impact factor: 1.875

9.  Sputum viscosity in chronic bronchitis, bronchiectasis, asthma and cystic fibrosis.

Authors:  J Charman; L Reid
Journal:  Biorheology       Date:  1972-09       Impact factor: 1.875

10.  THE ESTIMATION OF DEOXYRIBONUCLEIC ACID IN THE PRESENCE OF SIALIC ACID: APPLICATION TO ANALYSIS OF HUMAN GASTRIC WASHINGS.

Authors:  D N CROFT; M LUBRAN
Journal:  Biochem J       Date:  1965-06       Impact factor: 3.857

View more
  21 in total

1.  The efficiency of sputum cell counts in cystic fibrosis.

Authors:  L Jayaram; N R Labiris; A Efthimiadis; H Valchos-Mayer; F E Hargreave; A P Freitag
Journal:  Can Respir J       Date:  2007-03       Impact factor: 2.409

2.  The disulphide-bond content and rheological properties of intestinal mucins from normal subjects and patients with cystic fibrosis.

Authors:  M Mantle; G Stewart; G Zayas; M King
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

3.  Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease.

Authors:  C A Sheils; J Käs; W Travassos; P G Allen; P A Janmey; M E Wohl; T P Stossel
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis.

Authors:  R A Gottlieb; A Dosanjh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Serine proteases degrade airway mucins in cystic fibrosis.

Authors:  Markus O Henke; Gerrit John; Christina Rheineck; Shashi Chillappagari; Lutz Naehrlich; Bruce K Rubin
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

Review 6.  The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.

Authors:  M S Zach
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

Review 7.  New respiratory therapies in cystic fibrosis.

Authors:  D E Stableforth
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

8.  Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNase.

Authors:  K G Voelker; K G Chetty; C K Mahutte
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

9.  Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer.

Authors:  K Yoshimura; M A Rosenfeld; H Nakamura; E M Scherer; A Pavirani; J P Lecocq; R G Crystal
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

10.  Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.

Authors:  David J Serisier; Mary P Carroll; Janis K Shute; Simon A Young
Journal:  Respir Res       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.